Flanagan W. Michael 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Flanagan W. Michael（CIK 1841990）在 2 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-09-22）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-22 | Atrium Therapeutics, Inc. (RNA) | 董事 | 卖出 | 22,812 | $204,167 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Chief Scientific Officer | 卖出 | 150,365 | $0 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 卖出 | 3,976 | $288,061 |
| 2026-01-23 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 卖出 | 2,558 | $185,327 |
| 2026-01-09 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 卖出 | 2,373 | $171,402 |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 买入 | 27,500 | $0 |
| 2025-12-19 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 卖出 | 13,695 | $984,260 |
| 2025-09-12 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 买入 | 20,000 | $284,400 |
| 2025-09-12 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 卖出 | 20,000 | $778,800 |
| 2025-06-12 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 买入 | 20,000 | $284,400 |
| 2025-06-12 | Avidity Biosciences, Inc. (RNA) | Chief Scientific Officer | 卖出 | 20,000 | $657,600 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22